Literature DB >> 20181689

Effect of the internal promoter on insertional gene activation by lentiviral vectors with an intact HIV long terminal repeat.

Sean Knight1, Marieke Bokhoven, Mary Collins, Yasuhiro Takeuchi.   

Abstract

Insertional mutagenesis by viral vectors is a problem in gene therapy. We recently reported that lentiviral vectors with an intact HIV long terminal repeat (LTR) caused insertional gene activation by transcripts from the 5' LTR splicing to an adjacent gene. Here we demonstrate that the level of transcription from the 5' LTR, and also insertional gene activation, is dependent on the internal promoter in the vector. We also show that there are more transcripts originating from the 5' LTR than from, or reading through, the 3' LTR. This study will allow the design of safer lentiviral vectors for applications in which an intact HIV LTR is required.

Entities:  

Mesh:

Year:  2010        PMID: 20181689      PMCID: PMC2863782          DOI: 10.1128/JVI.02476-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  15 in total

1.  Genotoxic potential of lineage-specific lentivirus vectors carrying the beta-globin locus control region.

Authors:  Paritha I Arumugam; Tomoyasu Higashimoto; Fabrizia Urbinati; Ute Modlich; Shawna Nestheide; Ping Xia; Catherine Fox; Andrea Corsinotti; Christopher Baum; Punam Malik
Journal:  Mol Ther       Date:  2009-08-25       Impact factor: 11.454

Review 2.  Retroviral insertional mutagenesis: past, present and future.

Authors:  A G Uren; J Kool; A Berns; M van Lohuizen
Journal:  Oncogene       Date:  2005-11-21       Impact factor: 9.867

3.  Cell-culture assays reveal the importance of retroviral vector design for insertional genotoxicity.

Authors:  Ute Modlich; Jens Bohne; Manfred Schmidt; Christof von Kalle; Sabine Knöss; Axel Schambach; Christopher Baum
Journal:  Blood       Date:  2006-07-06       Impact factor: 22.113

4.  High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency [correction of imunodeficiency] virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter.

Authors:  Christophe Demaison; Kathryn Parsley; Gaby Brouns; Michaela Scherr; Karin Battmer; Christine Kinnon; Manuel Grez; Adrian J Thrasher
Journal:  Hum Gene Ther       Date:  2002-05-01       Impact factor: 5.695

5.  Gene transfer in humans using a conditionally replicating lentiviral vector.

Authors:  Bruce L Levine; Laurent M Humeau; Jean Boyer; Rob-Roy MacGregor; Tessio Rebello; Xiaobin Lu; Gwendolyn K Binder; Vladimir Slepushkin; Franck Lemiale; John R Mascola; Frederic D Bushman; Boro Dropulic; Carl H June
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-07       Impact factor: 11.205

6.  Efficient lentiviral vector-mediated control of HIV-1 replication in CD4 lymphocytes from diverse HIV+ infected patients grouped according to CD4 count and viral load.

Authors:  Laurent M Humeau; Gwendolyn K Binder; Xiaobin Lu; Vladimir Slepushkin; Randall Merling; Patricia Echeagaray; Mario Pereira; Tatiana Slepushkina; Scott Barnett; Lesia K Dropulic; Richard Carroll; Bruce L Levine; Carl H June; Boro Dropulic
Journal:  Mol Ther       Date:  2004-06       Impact factor: 11.454

7.  Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1.

Authors:  Salima Hacein-Bey-Abina; Alexandrine Garrigue; Gary P Wang; Jean Soulier; Annick Lim; Estelle Morillon; Emmanuelle Clappier; Laure Caccavelli; Eric Delabesse; Kheira Beldjord; Vahid Asnafi; Elizabeth MacIntyre; Liliane Dal Cortivo; Isabelle Radford; Nicole Brousse; François Sigaux; Despina Moshous; Julia Hauer; Arndt Borkhardt; Bernd H Belohradsky; Uwe Wintergerst; Maria C Velez; Lily Leiva; Ricardo Sorensen; Nicolas Wulffraat; Stéphane Blanche; Frederic D Bushman; Alain Fischer; Marina Cavazzana-Calvo
Journal:  J Clin Invest       Date:  2008-09       Impact factor: 14.808

8.  Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration.

Authors:  Eugenio Montini; Daniela Cesana; Manfred Schmidt; Francesca Sanvito; Maurilio Ponzoni; Cynthia Bartholomae; Lucia Sergi Sergi; Fabrizio Benedicenti; Alessandro Ambrosi; Clelia Di Serio; Claudio Doglioni; Christof von Kalle; Luigi Naldini
Journal:  Nat Biotechnol       Date:  2006-05-28       Impact factor: 54.908

9.  Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients.

Authors:  Steven J Howe; Marc R Mansour; Kerstin Schwarzwaelder; Cynthia Bartholomae; Michael Hubank; Helena Kempski; Martijn H Brugman; Karin Pike-Overzet; Stephen J Chatters; Dick de Ridder; Kimberly C Gilmour; Stuart Adams; Susannah I Thornhill; Kathryn L Parsley; Frank J T Staal; Rosemary E Gale; David C Linch; Jinhua Bayford; Lucie Brown; Michelle Quaye; Christine Kinnon; Philip Ancliff; David K Webb; Manfred Schmidt; Christof von Kalle; H Bobby Gaspar; Adrian J Thrasher
Journal:  J Clin Invest       Date:  2008-09       Impact factor: 14.808

10.  Interleukin 3 protects murine bone marrow cells from apoptosis induced by DNA damaging agents.

Authors:  M K Collins; J Marvel; P Malde; A Lopez-Rivas
Journal:  J Exp Med       Date:  1992-10-01       Impact factor: 14.307

View more
  17 in total

Review 1.  Biosafety features of lentiviral vectors.

Authors:  Axel Schambach; Daniela Zychlinski; Birgitta Ehrnstroem; Christopher Baum
Journal:  Hum Gene Ther       Date:  2013-02       Impact factor: 5.695

2.  Lentiviral vector induced insertional haploinsufficiency of Ebf1 causes murine leukemia.

Authors:  Dirk Heckl; Adrian Schwarzer; Reinhard Haemmerle; Doris Steinemann; Cornelia Rudolph; Britta Skawran; Sabine Knoess; Johanna Krause; Zhixiong Li; Brigitte Schlegelberger; Christopher Baum; Ute Modlich
Journal:  Mol Ther       Date:  2012-04-03       Impact factor: 11.454

3.  Intraosseous delivery of lentiviral vectors targeting factor VIII expression in platelets corrects murine hemophilia A.

Authors:  Xuefeng Wang; Simon C Shin; Andy F J Chiang; Iram Khan; Dao Pan; David J Rawlings; Carol H Miao
Journal:  Mol Ther       Date:  2015-02-06       Impact factor: 11.454

4.  Whole transcriptome characterization of aberrant splicing events induced by lentiviral vector integrations.

Authors:  Daniela Cesana; Jacopo Sgualdino; Laura Rudilosso; Stefania Merella; Luigi Naldini; Eugenio Montini
Journal:  J Clin Invest       Date:  2012-04-23       Impact factor: 14.808

5.  HIV- 1 lentivirus tethering to the genome is associated with transcription factor binding sites found in genes that favour virus survival.

Authors:  Saqlain Suleman; Annette Payne; Johnathan Bowden; Sharmin Al Haque; Marco Zahn; Serena Fawaz; Mohammad S Khalifa; Susan Jobling; David Hay; Matteo Franco; Raffaele Fronza; Wei Wang; Olga Strobel-Freidekind; Annette Deichmann; Yasuhiro Takeuchi; Simon N Waddington; Irene Gil-Farina; Manfred Schmidt; Michael Themis
Journal:  Gene Ther       Date:  2022-05-05       Impact factor: 5.250

6.  Safer, silencing-resistant lentiviral vectors: optimization of the ubiquitous chromatin-opening element through elimination of aberrant splicing.

Authors:  Sean Knight; Fang Zhang; Uta Mueller-Kuller; Marieke Bokhoven; Abhinav Gupta; Thomas Broughton; Sha Sha; Michael N Antoniou; Christian Brendel; Manuel Grez; Adrian J Thrasher; Mary Collins; Yasuhiro Takeuchi
Journal:  J Virol       Date:  2012-06-13       Impact factor: 5.103

7.  The β-globin locus control region in combination with the EF1α short promoter allows enhanced lentiviral vector-mediated erythroid gene expression with conserved multilineage activity.

Authors:  Claudia A Montiel-Equihua; Lin Zhang; Sean Knight; Heba Saadeh; Simone Scholz; Marlene Carmo; Maria E Alonso-Ferrero; Michael P Blundell; Aiste Monkeviciute; Reiner Schulz; Mary Collins; Yasuhiro Takeuchi; Manfred Schmidt; Lynette Fairbanks; Michael Antoniou; Adrian J Thrasher; H Bobby Gaspar
Journal:  Mol Ther       Date:  2012-03-20       Impact factor: 11.454

8.  A lentiviral gene therapy strategy for the in vitro production of feline erythropoietin.

Authors:  Natalia Vapniarsky; Michael Lame; Samantha McDonnel; Brian Murphy
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

9.  Predicting genotoxicity of viral vectors for stem cell gene therapy using gene expression-based machine learning.

Authors:  Adrian Schwarzer; Steven R Talbot; Anton Selich; Michael Morgan; Juliane W Schott; Oliver Dittrich-Breiholz; Antonella L Bastone; Bettina Weigel; Teng Cheong Ha; Violetta Dziadek; Rik Gijsbers; Adrian J Thrasher; Frank J T Staal; Hubert B Gaspar; Ute Modlich; Axel Schambach; Michael Rothe
Journal:  Mol Ther       Date:  2021-06-24       Impact factor: 11.454

10.  Retroviral and lentiviral vectors for the induction of immunological tolerance.

Authors:  Inès Dufait; Therese Liechtenstein; Alessio Lanna; Christopher Bricogne; Roberta Laranga; Antonella Padella; Karine Breckpot; David Escors
Journal:  Scientifica (Cairo)       Date:  2012-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.